Fact CheckerSign in

NCT02391051RecruitingPhase 2

Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial

Source: ClinicalTrials.gov · Last updated 11 Aug 2017 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This trial examines the feasibility and toxicity of focal brachytherapy in patients with low-risk prostate cancer.

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
50 (estimated)
First submitted
1 Jul 2014
Start date
Oct 2014
Primary completion date
Dec 2019
Lead sponsor
University of Erlangen-Nürnberg Medical School
NCT number
NCT02391051

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 50
  • From Oct 2014 to the primary completion date, Dec 2019
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Coagulation disorder

Other

  • Tumor stage ≥ T2b
  • Known metastasis: N+ and/or M1
  • General anesthesia or peridural anesthesia is not possible

Who the study is looking for

  • Age \> 18
  • Histologically confirmed prostate cancer
  • Gleason Score of index lesion ≤ 6 (3+3)
  • Tumor stage: cT1-2a cN0 cM0
  • Unilateral affection; index lesion ≤ 0.5ml with or without clinically non-significant lesion contralateral. No more than 25% of the punch should be affected. Therefore a 3D-TPM-biopsy is mandatory before treatment.
  • PSA ≤ 10/ng/ml
  • Prostate volume \< 60 m\^3
  • No distant metastasis
  • Life expectancy \> 10 years
  • Informed consent

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital
Coordinator of this site? Confirm its status
ErlangenGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.